| Day 1 - Morning Session |
| Part I: Welcome and Keynote Address |
| 8:00 A.M. |
Introductory comments:
Drs. Claude Lenfant, Aram Chobanian, and Martha Hill |
| 8:20 A.M. |
Overview of the relationship between
sodium and blood pressure
Dr. Paul Whelton |
| Part II: Response to Dietary Sodium and
Other Nutrients |
| 8:50 A.M. |
Differences in dietary responsiveness
to sodium intake
Dr. Myron Weinberger |
| 9:05 A.M. |
Discussion--Leaders: Drs. Margo Denke,
John Flack, and Steven Hunt |
| 9:35 A.M. |
Interactions of sodium, potassium, magnesium
and calcium in the regulation of blood pressure
Dr. Frank Sacks |
| 9:50 A.M. |
Discussion--Leaders: Drs. Theodore Kotchen,
David McCarron, and Laura Svetkey |
| 10:15 A.M. |
BREAK |
| Part III: Sodium and Blood Pressure in
the Young |
| 10:30 A.M. |
Effects of neonatal sodium intake
Dr. Ronald Prineas |
| 10:45 A.M. |
Sodium intake and blood pressure in
children
Dr. Bonita Falkner |
| 11:00 A.M. |
Discussion--Leaders: Drs. Gerald Berenson,
Clarence Grim, and Julie Ingelfinger |
| 11:30 A.M. |
General Discussion |
| 12:00-1:00 P.M. |
LUNCH |
| Day 1 - Afternoon Session |
| Part IV: Clinical Trials and Clinical
Studies |
| 1:00 P.M. |
Meta-analysis of clinical trials of
sodium reduction:
Dr. Niels Graudal |
| 1:20 P.M. |
Sodium reduction in subpopulations (age,
race, gender):
Dr. Richard Grimm |
| 1:40 P.M. |
The prevalence of sodium sensitivity
in postmenopausal women:
Dr. Janice Douglas |
| 2:00 P.M. |
Sodium reduction and quality of life:
Dr. Shiriki Kumanyika |
| 2:20 P.M. |
Discussion--Leaders: Drs. Lawrence Appel,
David Freedman, Diana Petitti, James Robins, and Michael
Stoto |
| 3:00 P.M. |
BREAK |
| Part V: Observational Studies |
| 3:15 P.M. |
INTERSALT:
Dr. Paul Elliott |
| 3:30 P.M. |
Worksite Cohort, NHANES I, and Scotland
Study
Dr. Christopher Sempos |
| 3:45 P.M. |
MRFIT-Followup:
Dr. Jerome Cohen |
| 4:00 P.M. |
Discussion--Leaders: Drs. Nancy Cook, Graham
MacGregor, and Louis Tobian |
| 4:45 P.M. |
ADJOURNMENT |
| Day 2 - Morning Session |
| Part VI: Other Data |
| 8:00 A.M. |
Non-CVD conditions:
Dr. Daniel Jones |
| 8:15 A.M. |
Left ventricular mass:
Dr. Richard Devereaux |
| 8:30 A.M. |
Discussion--Leaders: Drs. Jay Cohn, Edward
Frohlich and Lewis Kuller |
| Part VII: Physiological Effects of Very
Low Sodium Intake |
| 9:00 A.M. |
Renin-angiotensin system:
Dr. Suzanne Oparil |
| 9:15 A.M. |
Sympathetic nervous system:
Dr. Allyn Mark |
| 9:30 A.M. |
Plasma insulin, cholesterol and coagulation
factors:
Dr. Brent M. Egan |
| 9:45 A.M. |
Discussion--Leaders: Drs. Richard Cooper,
Carlos Ferrario, and Gordon Williams |
| 10:15 A.M. |
BREAK |
| Part VIII: Research Needs |
| 10:30 A.M. |
Basic research:
Dr. Allen Cowley |
| 10:50 A.M. |
Clinical/epidemiological research:
Dr. Lawrence Appel |
| 11:10 A.M. |
Discussion--Leaders: Drs. Harry Gavras,
David Goff, John Hall, and John McGiff |
| 11:40 A.M. |
Should there be a randomized clinical
trial on sodium reduction and blood pressure with morbidity/mortality
as an outcome?
Drs. Daniel Jones, Alexander Logan, Ronald Prineas, and
Jeremiah Stamler |
| 12:00 |
General discussion: research considerations |
| 12:30-1:30 P.M. |
LUNCH |
| Day 2 - Afternoon Session |
| Part IX: Public Policy Considerations |
| 1:30 P.M. |
Dietary guidance public policy:
Dr. Michael McGinnis |
| 1:50 P.M. |
Discussion--Leaders: Drs. Johanna Dwyer,
William Harlan, Marion Nestle, and Meir Stampfer |
| 2:30 P.M. |
General discussion: policy considerations
|
| 3:15 P.M. |
Chairpersons' concluding remarks |
| 3:45 P.M. |
ADJOURNMENT |
Get Email Alerts
Twitter
Facebook
YouTube